PharmaIN Corp.
- Biotech or pharma, therapeutic R&D
PharmaIN is developing a novel peptide therapeutic for patients with advanced cirrhosis.
Our lead program is currently in phase 1:
Phase 1 Single ascending dose in advanced cirrhosis: complete
Phase 1 Multiple ascending dose: enrolling
Compelling evidence of clinical benefit after a single dose
We are actively seeking collaboration or out-licensing opportunities, as well as investment partners.
**We are not accepting meetings with CROs, CMOs, and consultants**
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}